The differential response of glioma stem cells to SHH ligand, as compared to non-stem glioblastoma cells, highlights the potential of SHH pathway-targeted approaches as an effective single-cell killing strategy specifically against the stem-like tumor subpopulation31. Here, SHH is linked to central nervous system cancer.